InMed Pharmaceuticals Inc — Quarterly Results & Earnings

₹179.50

-0.97%

Profit Growth YoY-25.48%Latest quarter

Sales Growth YoY24.29%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth-25.48%

🔴 Significant decline

YoY Sales Growth+24.29%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

N/A

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

10.41

ROE

19.56%

ROCE

21.67%

💡

Growth Analysis

InMed Pharmaceuticals Inc reported YoY profit growth of -25.48% and revenue growth of 24.29% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on InMed Pharmaceuticals Inc

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Furniture, Home Furnishing Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.